Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men.
暂无分享,去创建一个
S. Cummings | J. Cauley | E. Barrett-Connor | P. Cawthon | D. Bauer | J. Shikany | K. Ensrud | A. Hoffman | N. Lane | E. Orwoll | N. Parimi | G. Laughlin
[1] W. Willett,et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. , 2006, The American journal of clinical nutrition.
[2] H. Rayner,et al. Hyperparathyroidism associated with severe hypercalcaemia and myocardial calcification despite minimal bone disease. , 1986, British medical journal.
[3] Markku Heliövaara,et al. Vitamin D status and the risk of cardiovascular disease death. , 2009, American journal of epidemiology.
[4] A. Jette,et al. The Physical Activity Scale for the Elderly (PASE): development and evaluation. , 1993, Journal of clinical epidemiology.
[5] P. Delmas,et al. Serum concentrations of 17β‐E2 and 25‐hydroxycholecalciferol (25OHD) in relation to all‐cause mortality in older men – the MINOS study , 2009, Clinical endocrinology.
[6] C. Held,et al. Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community , 2009, Circulation.
[7] Edward Giovannucci,et al. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States) , 2005, Cancer Causes & Control.
[8] L. Ferrucci,et al. Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. , 2009, Nutrition research.
[9] Barrett T. Kitch,et al. Hypovitaminosis D in medical inpatients. , 1998, The New England journal of medicine.
[10] G. Riedmüller,et al. Low Serum Levels of 25-Hydroxyvitamin D Predict Fatal Cancer in Patients Referred to Coronary Angiography , 2008, Cancer Epidemiology Biomarkers & Prevention.
[11] J. Souberbielle,et al. Third- or second-generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. , 2005, The Journal of clinical endocrinology and metabolism.
[12] B. Astor,et al. 25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population , 2008 .
[13] M. McKenna,et al. Differences in vitamin D status between countries in young adults and the elderly. , 1992, The American journal of medicine.
[14] B. Graubard,et al. Prospective study of serum vitamin D and cancer mortality in the United States. , 2007, Journal of the National Cancer Institute.
[15] Tom Greene,et al. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate , 2006, Annals of Internal Medicine.
[16] M. Holick. Vitamin D deficiency. , 2007, The New England journal of medicine.
[17] F. Fortune,et al. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association. , 1985, British heart journal.
[18] J. Cauley,et al. Vitamin D deficiency in older men. , 2009, The Journal of clinical endocrinology and metabolism.
[19] R. Recker,et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.
[20] S. Cummings,et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.
[21] Stefan Pilz,et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.
[22] S. Bandinelli,et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults , 2009, European Journal of Clinical Nutrition.
[23] M. Holick. High prevalence of vitamin D inadequacy and implications for health. , 2006, Mayo Clinic proceedings.
[24] V. Arndt,et al. Meta‐analysis: longitudinal studies of serum vitamin D and colorectal cancer risk , 2009, Alimentary pharmacology & therapeutics.
[25] S. Cole,et al. Invited Commentary: Causal diagrams and measurement bias. , 2009, American journal of epidemiology.
[26] E. Hagström,et al. Correlation between plasma calcium, parathyroid hormone (PTH) and the metabolic syndrome (MetS) in a community‐based cohort of men and women , 2009, Clinical endocrinology.
[27] I. Reid,et al. Vitamin D insufficiency and health outcomes over 5 y in older women. , 2010, The American journal of clinical nutrition.
[28] E. Shahar. The association of body mass index with health outcomes: causal, inconsistent, or confounded? , 2009, American journal of epidemiology.
[29] J. Rastad,et al. Clinical presentation of primary hyperparathyroidism in Europe--nationwide cohort analysis on mortality from nonmalignant causes. , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] E. Rydberg,et al. Primary hyperparathyroidism and heart disease--a review. , 2004, European heart journal.
[31] H. Brenner,et al. Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. , 2009, Cancer epidemiology.
[32] John Robbins,et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.
[33] D. Albanes,et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. , 2006, Cancer research.
[34] Vitamin D and cancer mortality. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[35] Sara Gandini,et al. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. , 2007, Archives of internal medicine.
[36] G. Nijpels,et al. Vitamin D and mortality in older men and women , 2009, Clinical endocrinology.
[37] Odén,et al. Increased risk of death from primary hyperparathyroidism — an update , 1998, European journal of clinical investigation.
[38] R. Cumming,et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. , 2004, The Journal of clinical endocrinology and metabolism.
[39] G Block,et al. Validation of a self-administered diet history questionnaire using multiple diet records. , 1990, Journal of clinical epidemiology.